Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma
Clinical trial NCT04291885 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04291885
- Sponsor
- Melanoma and Skin Cancer Trials Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-26
- Primary completion
- 2027-04-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.